A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

Experts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...

Gastrointestinal stromal tumors (GIST) are rare mesenchymal tumors and were among the first solid tumor types for which such a novel treatment (in this case imatinib) became available. The ...

Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with earlier cohorts.